The CRTAP gene helps your body build and organize collagen, a key material that gives bones and connective tissue strength. This gene plays an important role in keeping the body’s supporting tissues stable. When it does not work properly, collagen is made abnormally, which can lead to fragile bones, short stature, joint laxity, and sometimes breathing problems. Pathogenic variants in the CRTAP gene can cause a form of osteogenesis imperfecta, a condition in which bones break more easily.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or guiding processes in the body. Some genes carry the code for proteins, which are the parts of cells that do much of the work. Other genes are mainly involved in controlling when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To go deeper into this topic, you can find more in the LearnHub.
Overview
CRTAPGene function
What if the gene works
The CRTAP gene helps your body build and process type I collagen, a key support protein in bone and connective tissue. This supports normal bone strength and growth.
Risk
What if the gene does not work
Variants that reduce function of the CRTAP gene can cause a form of osteogenesis imperfecta, with fragile bones, frequent fractures, short stature, and growth problems. Milder to more severe variants may affect how early features appear and how pronounced they are.
Treatment
What does that mean for your treatment
No CRTAP-specific treatment or drug choice approach is currently established. Management usually follows standard osteogenesis imperfecta care, and the CRTAP gene is being studied mainly to understand bone fragility rather than to guide a targeted medicine.
Conditions associated with CRTAP
Gene function
What if the gene works
Your cells use the CRTAP gene while they build collagen, a protein that gives bone and other connective tissues their basic strength and shape. Its main job is to help prepare collagen inside the cell so it can fold correctly and be used in the body's support framework. Understanding how the CRTAP gene supports collagen building helps show its day to day role in healthy tissue upkeep.
The protein made from the CRTAP gene helps your cells add a small chemical mark to certain collagen building blocks. That finishing step helps collagen mature in a controlled way before tissues use it.
The CRTAP gene works with partner proteins to help collagen chains form their stable three strand shape. This makes collagen easier for your cells to handle as it is prepared for use.
By helping collagen mature properly, the CRTAP gene supports the body's internal framework in bone, cartilage, and other connective tissues. This steady support role is central to what the CRTAP gene does in the body.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
How variants influence the CRTAP gene's function depends on how much they weaken or stop production of the CRTAP protein, disturbing a collagen processing complex and causing delayed collagen folding, chemical changes, and less stable collagen between cells. Milder variants may leave some activity, while more severe variants can remove it completely. In people with a brittle bone condition (osteogenesis imperfecta) linked to the CRTAP gene, this often means earlier onset and more fractures.
How variants are linked to conditions
Pathogenic variants in the CRTAP gene cause osteogenesis imperfecta type VII, a rare inherited condition marked by fragile bones, frequent fractures, short stature, and growth problems. In people with two disease-causing variants in the CRTAP gene, the diagnosis can be confirmed genetically, although severity can range from very severe before birth to milder bone fragility later in childhood. This makes CRTAP gene variants linked to osteogenesis imperfecta type VII the main well-established condition association for this gene.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also play a role. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CRTAP, risk is mostly shaped by inheritance rather than lifestyle. A child’s chance of having a CRTAP-related bone condition is higher when both parents carry a changed copy of the CRTAP gene; after that, there is not enough evidence to say that diet, exercise, or other habits lower the chance of developing the condition.
Inheritance of CRTAP variants
Variants in the CRTAP gene are inherited in an autosomal recessive pattern. This means a child usually inherits one altered copy from each parent, and both parents are typically carriers who often do not have symptoms. When both parents carry a CRTAP gene variant, each pregnancy has a 25% chance of resulting in a child with the condition, a 50% chance of producing a carrier child, and a 25% chance of producing a child without the familial variant. This is the main pattern seen in how CRTAP gene variants are inherited.
What does my CRTAP result mean for my family?
For families, a CRTAP result usually matters most in a recessive pattern. Parents of a child with a CRTAP-related condition are often healthy carriers, and brothers, sisters, and other close relatives may also be carriers. If both parents carry a changed CRTAP copy, future children could also be born with the condition.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the CRTAP gene, doctors use genetic testing on a blood or saliva sample. CRTAP genetic testing reads the DNA code and can identify variants linked with certain inherited bone conditions, helping clarify whether a person’s symptoms fit a genetic diagnosis and whether family members may also carry the variant.
When should I consider getting a genetic test?
Genetic testing for the CRTAP gene may be worth considering when a baby, child, or adult has unusually fragile bones, repeated fractures from minor falls, very short stature, or other signs of osteogenesis imperfecta, a condition that weakens bone. It can also help if there is a family history of this condition or a known CRTAP variant in the family.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, yet how much it reveals depends on the condition and on the type of variant involved. How the body functions over time is also shaped by many influences, including age, lifestyle, environment, and medical history. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is best viewed alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication may work well for one person, have less effect in another, or cause more side effects in someone else. These differences are common and are one reason treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines the way genetic differences can shape a person’s response to medicines. It studies links between genes and medications to help explain why the same treatment may affect people in different ways. With many drugs, genes influence both how powerfully a medicine works and how the body handles it. Understanding this can support treatment choices that are better informed and more individualized. More information on this topic is available in the LearnHub.
Drugs influenced by the CRTAP gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so routine medication decisions are not usually based on it. If you have concerns about side effects, how well a treatment is working, or medicine safety, talk with your doctor or pharmacist.
History
CRTAP entered medical genetics through studies of cartilage and bone, and its importance became much clearer in the early 2000s. Initially understood only through visible traits, later recognized as tied to a specific gene, this work helped researchers connect rare inherited brittle bone conditions with changes beyond the better known collagen genes. A major step came in 2006, when pathogenic variants in the CRTAP gene were linked to recessive forms of osteogenesis imperfecta. From these first observations, research expanded steadily. That shift widened the picture of how osteogenesis imperfecta can run in families and showed that not all cases follow the same inheritance pattern. Since then, CRTAP has remained part of the broader story of how rare bone conditions reshaped modern genetic diagnosis.